Keith Rosenbloom Sells 556,580 Shares of American Vanguard (NYSE:AVD) Stock

American Vanguard Corporation (NYSE:AVD) Director Keith Rosenbloom sold 556,580 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $2.20, for a total transaction of $1,224,476.00. Following the sale, the director directly owned 15,201 shares of the company’s stock, valued at approximately $33,442.20. This represents a 97.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

American Vanguard Price Performance

AVD stock traded down $0.12 during mid-day trading on Thursday, reaching $2.23. The company’s stock had a trading volume of 273,132 shares, compared to its average volume of 322,056. The company has a current ratio of 2.47, a quick ratio of 1.40 and a debt-to-equity ratio of 1.46. The company’s 50 day moving average is $2.58 and its two-hundred day moving average is $3.12. American Vanguard Corporation has a fifty-two week low of $2.03 and a fifty-two week high of $5.92. The stock has a market cap of $65.78 million, a PE ratio of -1.17 and a beta of 1.43.

American Vanguard (NYSE:AVD) last posted its quarterly earnings results on Monday, August 10th. The basic materials company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.43). American Vanguard had a negative net margin of 10.70% and a negative return on equity of 9.05%. The company had revenue of $116.75 million during the quarter, compared to analysts’ expectations of $135.00 million.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on AVD shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Vanguard in a research note on Thursday, August 13th. Wall Street Zen cut shares of American Vanguard from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, American Vanguard currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its position in American Vanguard by 117.8% in the first quarter. AQR Capital Management LLC now owns 436,687 shares of the basic materials company’s stock worth $1,921,000 after acquiring an additional 236,212 shares during the period. Jane Street Group LLC lifted its stake in shares of American Vanguard by 287.6% in the 1st quarter. Jane Street Group LLC now owns 40,509 shares of the basic materials company’s stock valued at $178,000 after purchasing an additional 30,058 shares during the last quarter. Acadian Asset Management LLC grew its holdings in shares of American Vanguard by 1,732.4% during the 1st quarter. Acadian Asset Management LLC now owns 58,234 shares of the basic materials company’s stock worth $253,000 after purchasing an additional 55,056 shares during the period. Strs Ohio purchased a new position in shares of American Vanguard during the 1st quarter worth $28,000. Finally, Geode Capital Management LLC increased its position in shares of American Vanguard by 2.2% during the 2nd quarter. Geode Capital Management LLC now owns 639,301 shares of the basic materials company’s stock worth $2,506,000 after purchasing an additional 13,657 shares during the last quarter. 79.00% of the stock is currently owned by institutional investors and hedge funds.

About American Vanguard

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.